ATEX.NASDAQAnterix INC

Form 4: Anterix Executive Chairman Sells Shares in Open Market Transaction

Sentiment:

SEC Form 4 Filing


Anterix's Executive Chairman, Morgan E. O'Brien, sold 13,609 shares of common stock at an average price of $33.44 on December 16, 2024.

Summary

  • Morgan E. O'Brien, the Executive Chairman of Anterix Inc., sold 13,609 shares of common stock on December 16, 2024.
  • The shares were sold at a weighted average price of $33.44 per share.
  • The sale was executed through multiple transactions with prices ranging from $33.34 to $33.55.
  • Following the transaction, Mr. O'Brien directly owns 23,973 shares of Anterix common stock.

Sentiment

Score: 5

Explanation: The document reports a routine insider stock sale, which is neither positive nor negative for the company's outlook. It's a neutral event.

Industry Context

This is a routine disclosure of an insider transaction and does not necessarily indicate a change in the company's outlook or performance. It is common for executives to sell shares for personal financial management.

Comparison to Industry Standards

  • Executive stock sales are a common occurrence in publicly traded companies.
  • The sale by Morgan E. O'Brien is within the normal range of insider transactions.
  • Similar transactions are regularly reported by executives at comparable companies such as Ligado Networks and Rivada Space Networks.

Stakeholder Impact

  • The stock sale may have a minor impact on the stock price in the short term, but is unlikely to have a significant long-term effect.
  • The transaction does not directly impact employees, customers, or suppliers.

Key Dates

DateDescription
12/16/2024Date of the stock sale transaction.
12/17/2024Date the Form 4 was signed.

Keywords

Anterix, stock sale, insider trading, executive chairman, Morgan E. O'Brien, ATEX

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.